ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
The Impact of Testosterone on Metformin Action on Hypothalamic-Pituitary-Thyroid Axis Activity in Men
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 156206" data-attributes="member: 13851"><p><strong>Abstract </strong></p><p></p><p><span style="color: rgb(184, 49, 47)"><strong>The effect of metformin on thyrotrope function seems to be sex dependent.The aim of this study was to determine the role of endogenous testosterone in the impact of metformin on hypothalamic-pituitary-thyroid axis activity. </strong></span>The study population consisted of 2 groups of men with nonautoimmune hypothyroidism matched for age,weight,insulin sensitivity,and thyrotropin levels.The first group (n = 11) included subjects with low serum testosterone levels,while the second (n = 12) men with testosterone levels within the reference range. Because of concomitant type 2 diabetes, all men were treated with metformin (2550-3000 mg daily).Circulating levels of glucose, prolactin, testosterone, gonadotropins, thyrotropin, and free thyroid hormones were measured, while the structure parameters of thyroid homeostasis and the degree of insulin sensitivity were calculated at baseline and 16 weeks later.<span style="color: rgb(184, 49, 47)"><strong> In both study groups, metformin decreased plasma glucose levels and improved insulin sensitivity.</strong></span> <span style="color: rgb(26, 188, 156)"><strong>However, only in men with low testosterone levels, the drug decreased thyrotropin levels, reduced Jostel’s thyrotropin index, and increased SPINA-GT. Metformin-induced changes in thyrotropin and Jostel’s index correlated with their baseline values, baseline levels of testosterone, and with the effect of treatment on insulin sensitivity.</strong></span> <span style="color: rgb(44, 130, 201)"><strong>In men with neither low or normal testosterone levels, metformin affected free thyroid hormones, prolactin, testosterone, gonadotropins, and SPINA-GD. The obtained results suggest that the impact of metformin on thyrotrope function depends on the androgen status of a patient.</strong></span></p><p></p><p></p><p></p><p></p><p></p><p>Some study limitations merit comment. The most important limitation is the small sample size, resulting from difficulties in including in one research center a larger group of untreated patients with new-onset type 2 diabetes mellitus, nonautoimmune subclinical hypothyroidism, and late-onset hypogonadism. Second, because the real meaning of changes in Jostel’s thyrotropin index and SPINA-GT is still unclear, the obtained results should be interpreted with caution. Moreover, taking into account that the participants <em>were characterized by low selenium status34 and adequate iodine intake,35 it is not certain whether the impact of metformin is the same in areas with adequate selenium and inadequate iodine consumption. Furthermore, it remains to be elucidated whether metformin affects hypothalamic-pituitary-thyroid axis activity in men with thyroid hypothyroidism of autoimmune origin. Finally, the question of whether endogenous testosterone determines metformin action on thyrotrope function in subjects with normal or only slightly impaired insulin sensitivity requires further research.</em></p><p></p><p></p><p></p><p></p><p></p><p><span style="color: rgb(184, 49, 47)"><strong>To sum up, despite improving glucose homeostasis in both study groups,</strong></span> <span style="color: rgb(26, 188, 156)"><strong>metformin decreased thyrotropin levels, lowered Jostel’s thyrotropin index, and increased SPINA-GT only in men with low testosterone levels. </strong></span><span style="color: rgb(44, 130, 201)"><strong>The effect of treatment on thyrotropin and Jostel’s thyrotropin index depended on baseline levels of thyrotropin and testosterone, as well as correlated with the impact of metformin on insulin sensitivity. These findings suggest that metformin action on the hypothalamic-pituitary-thyroid axis activity depends on the androgen status of a patient.</strong></span> <strong>Because of the small sample size, the current study should be regarded as a pilot study, and larger multicenter trials are required to confirm the obtained results. </strong></p></blockquote><p></p>
[QUOTE="madman, post: 156206, member: 13851"] [B]Abstract [/B] [COLOR=rgb(184, 49, 47)][B]The effect of metformin on thyrotrope function seems to be sex dependent.The aim of this study was to determine the role of endogenous testosterone in the impact of metformin on hypothalamic-pituitary-thyroid axis activity. [/B][/COLOR]The study population consisted of 2 groups of men with nonautoimmune hypothyroidism matched for age,weight,insulin sensitivity,and thyrotropin levels.The first group (n = 11) included subjects with low serum testosterone levels,while the second (n = 12) men with testosterone levels within the reference range. Because of concomitant type 2 diabetes, all men were treated with metformin (2550-3000 mg daily).Circulating levels of glucose, prolactin, testosterone, gonadotropins, thyrotropin, and free thyroid hormones were measured, while the structure parameters of thyroid homeostasis and the degree of insulin sensitivity were calculated at baseline and 16 weeks later.[COLOR=rgb(184, 49, 47)][B] In both study groups, metformin decreased plasma glucose levels and improved insulin sensitivity.[/B][/COLOR] [COLOR=rgb(26, 188, 156)][B]However, only in men with low testosterone levels, the drug decreased thyrotropin levels, reduced Jostel’s thyrotropin index, and increased SPINA-GT. Metformin-induced changes in thyrotropin and Jostel’s index correlated with their baseline values, baseline levels of testosterone, and with the effect of treatment on insulin sensitivity.[/B][/COLOR] [COLOR=rgb(44, 130, 201)][B]In men with neither low or normal testosterone levels, metformin affected free thyroid hormones, prolactin, testosterone, gonadotropins, and SPINA-GD. The obtained results suggest that the impact of metformin on thyrotrope function depends on the androgen status of a patient.[/B][/COLOR] Some study limitations merit comment. The most important limitation is the small sample size, resulting from difficulties in including in one research center a larger group of untreated patients with new-onset type 2 diabetes mellitus, nonautoimmune subclinical hypothyroidism, and late-onset hypogonadism. Second, because the real meaning of changes in Jostel’s thyrotropin index and SPINA-GT is still unclear, the obtained results should be interpreted with caution. Moreover, taking into account that the participants [I]were characterized by low selenium status34 and adequate iodine intake,35 it is not certain whether the impact of metformin is the same in areas with adequate selenium and inadequate iodine consumption. Furthermore, it remains to be elucidated whether metformin affects hypothalamic-pituitary-thyroid axis activity in men with thyroid hypothyroidism of autoimmune origin. Finally, the question of whether endogenous testosterone determines metformin action on thyrotrope function in subjects with normal or only slightly impaired insulin sensitivity requires further research.[/I] [COLOR=rgb(184, 49, 47)][B]To sum up, despite improving glucose homeostasis in both study groups,[/B][/COLOR] [COLOR=rgb(26, 188, 156)][B]metformin decreased thyrotropin levels, lowered Jostel’s thyrotropin index, and increased SPINA-GT only in men with low testosterone levels. [/B][/COLOR][COLOR=rgb(44, 130, 201)][B]The effect of treatment on thyrotropin and Jostel’s thyrotropin index depended on baseline levels of thyrotropin and testosterone, as well as correlated with the impact of metformin on insulin sensitivity. These findings suggest that metformin action on the hypothalamic-pituitary-thyroid axis activity depends on the androgen status of a patient.[/B][/COLOR] [B]Because of the small sample size, the current study should be regarded as a pilot study, and larger multicenter trials are required to confirm the obtained results. [/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
The Impact of Testosterone on Metformin Action on Hypothalamic-Pituitary-Thyroid Axis Activity in Men
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top